Media Advisory - Patient group discusses benefits of Canada-EU trade deal for Canadian patients

OTTAWA, Oct. 17, 2013 /CNW/ - The Mood Disorders Society of Canada is encouraged that Canada and the European Union are moving to finalize a trade agreement that promises to help improve mental health care for Canadian patients.

The Comprehensive Economic and Trade Agreement (CETA) provides an opportunity to strengthen Canada's intellectual property regime, ensuring continued research and innovation in medicines for all Canadians, including those living with mental illness.

Phil Upshall, Executive Director of the Mood Disorders Society of Canada, is available to discuss the organization's perspective on CETA.

About the Mood Disorders Society of Canada:
The Mood Disorders Society of Canada was launched in 2001 to provide people with mood disorders, their families and caregivers a strong, cohesive voice at the national level on issues relating to mental health and mental illness. With particular regard to depression, bipolar disorder and other associated mood disorders, the MDSC aims to improve access to treatment, inform research, shape program development and government policy to improve the quality of life for people affected by mood disorders.

SOURCE: Mood Disorders Society of Canada

To make arrangements for interviews, please contact:

Jacquie LaRocque
[email protected]
[phone]